Advancing the frontiers of clinical drug development

CHDR is an independent institute specialising in innovative early-stage clinical drug research.

Our Story Our Unit


Investment of 9.5 million euros in Dutch facility for faster development of medi...

05 Apr 2024

The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in...

20 Mar 2024

Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success

A ‘one-stop-shop’ for all cardiology needs

A robust tool for experimentally inducing panic attacks in order to test new anxiolytics

A series of in vivo, ex vivo, and in vitro tools to induce inflammation in healthy volunteers and cells